Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXV
Proceedings Volume 9694 is from: Logo
13-18 February 2016
San Francisco, California, United States
Front Matter: Volume 9694
Proc. SPIE 9694, Front Matter: Volume 9694, 969401 (26 April 2016); doi: 10.1117/12.2231318
Photodynamic Therapy I
Proc. SPIE 9694, Mechanistic studies on a sequential PDT protocol, 969402 (1 March 2016); doi: 10.1117/12.2214924
Proc. SPIE 9694, Spatiotemporally synchronized cancer combination therapy using photo-activated nanoparticle drug delivery systems (Conference Presentation), 969403 (26 April 2016); doi: 10.1117/12.2217533
Proc. SPIE 9694, Designing PDT-based combinations to overcome chemoresistance in heterocellular 3D tumor models (Conference Presentation), 969404 (26 April 2016); doi: 10.1117/12.2213436
Photodynamic Therapy II
Proc. SPIE 9694, Critical dosimetry measures and surrogate tools that can facilitate clinical success in PDT (Conference Presentation), 969405 (26 April 2016); doi: 10.1117/12.2208777
Proc. SPIE 9694, A feasibility study of singlet oxygen explicit dosmietry (SOED) of PDT by intercomparison with a singlet oxygen luminescence dosimetry (SOLD) system, 969406 (1 March 2016); doi: 10.1117/12.2213236
Proc. SPIE 9694, Combination of verteporfin-PDT and PI3K inhibitors enhances cell growth inhibition and apoptosis in endothelial cells, 969407 (1 March 2016); doi: 10.1117/12.2213419
Proc. SPIE 9694, Pancreas tumor interstitial pressure catheter measurement, 969408 (5 April 2016); doi: 10.1117/12.2214181
Photodynamic Therapy III
Proc. SPIE 9694, Photodynamic therapy with simultaneous suppression of multiple treatment escape pathways (Conference Presentation), 969409 (26 April 2016); doi: 10.1117/12.2213828
Proc. SPIE 9694, Predicting photodynamic therapy efficacy with photoacoustic imaging (Conference Presentation), 96940A (26 April 2016); doi: 10.1117/12.2217889
Proc. SPIE 9694, Activation of photodynamic therapy in vitro with Cerenkov luminescence generated from Yttrium-90 (Conference Presentation), 96940B (26 April 2016); doi: 10.1117/12.2213920
Proc. SPIE 9694, Development of low-cost devices for image-guided photodynamic therapy treatment of oral cancer in global health settings, 96940C (1 March 2016); doi: 10.1117/12.2212918
Proc. SPIE 9694, Determination of the low concentration correction in the macroscopic singlet oxygen model for PDT, 96940D (17 March 2016); doi: 10.1117/12.2213417
Photodynamic Therapy IV
Proc. SPIE 9694, Combination photodynamic therapy using 5-fluorouracil and aminolevulinate enhances tumor-selective production of protoporphyrin IX and improves treatment efficacy of squamous skin cancers and precancers, 96940E (1 March 2016); doi: 10.1117/12.2218138
Proc. SPIE 9694, Preliminary studies of fluorescence image-guided photothermal therapy of human oesophageal adenocarcinoma in vivo using multifunctional gold nanorods, 96940G (1 March 2016); doi: 10.1117/12.2212337
Proc. SPIE 9694, Detection techniques for singlet oxygen production during photodynamic therapy (Conference Presentation), 96940H (26 April 2016); doi: 10.1117/12.2211266
Proc. SPIE 9694, Home-use cancer detecting band aid, 96940I (1 March 2016); doi: 10.1117/12.2210808
Photodynamic Therapy V
Proc. SPIE 9694, Extracellular matrix composition and rigidity regulate invasive behavior and response to PDT in 3D pancreatic tumor models , 96940J (5 April 2016); doi: 10.1117/12.2213843
Proc. SPIE 9694, Vitamin D for combination photodynamic therapy of skin cancer in individuals with vitamin D deficiency: Insights from a preclinical study in a mouse model of squamous cell carcinoma, 96940K (1 March 2016); doi: 10.1117/12.2214463
Proc. SPIE 9694, Investigating the impact of oxygen concentration and blood flow variation on photodynamic therapy, 96940L (1 March 2016); doi: 10.1117/12.2211120
Proc. SPIE 9694, Adapting biomodulatory strategies for treatment in new contexts: pancreatic and oral cancers (Conference Presentation), 96940M (26 April 2016); doi: 10.1117/12.2213922
Photodynamic Therapy VI
Proc. SPIE 9694, Multi-spectral wide-field imaging for PplX PDT dosimetry of skin (Conference Presentation), 96940N (26 April 2016); doi: 10.1117/12.2213463
Proc. SPIE 9694, Molecular targeted PDT with selective delivery of ICG Photo-Immunoconjugates (Conference Presentation), 96940O (26 April 2016); doi: 10.1117/12.2217572
Proc. SPIE 9694, Reducing background noise in near-infrared medical imaging: Routes to activated fluorescing, 96940P (1 March 2016); doi: 10.1117/12.2218037
Proc. SPIE 9694, Efficiency of photodynamic therapy using indocyanine green and infrared light on MCF-7 breast cancer cells in vitro, 96940Q (1 March 2016); doi: 10.1117/12.2214308
Photodynamic Therapy VII
Proc. SPIE 9694, Two-photon photodynamic properties of TBO-AuNR-in-shell nanoparticles (Conference Presentation), 96940S (26 April 2016); doi: 10.1117/12.2212229
Proc. SPIE 9694, Dosimetry study of PHOTOFRIN-mediated photodynamic therapy in a mouse tumor model, 96940T (1 March 2016); doi: 10.1117/12.2211169
Proc. SPIE 9694, Site-specific antibody-liposome conjugation through copper-free click chemistry: a molecular biology approach for targeted photodynamic therapy (Conference Presentation), 96940U (26 April 2016); doi: 10.1117/12.2214253
Proc. SPIE 9694, Repurposing of tetracyclines to overcome resistance pathways associated with photochemotherapy in cancer (Conference Presentation), 96940V (26 April 2016); doi: 10.1117/12.2217949
Photodynamic Therapy VIII
Proc. SPIE 9694, Mechanistic exploration of a bi-directional PDT-based combination in pancreatic cancer (Conference Presentation), 96940W (26 April 2016); doi: 10.1117/12.2217925
Proc. SPIE 9694, Cherenkov radiation fluence estimates in tissue for molecular imaging and therapy applications, 96940X (1 March 2016); doi: 10.1117/12.2209126
Proc. SPIE 9694, PDT dose dosimeter for pleural photodynamic therapy, 96940Y (17 March 2016); doi: 10.1117/12.2213401
Proc. SPIE 9694, Analysis of superficial fluorescence patterns in nonmelanoma skin cancer during photodynamic therapy by a dosimetric model, 96940Z (1 March 2016); doi: 10.1117/12.2208678
Poster Session
Proc. SPIE 9694, Optical spectroscopy of radiotherapy and photodynamic therapy responses in normal rat skin shows vascular breakdown products, 969410 (1 March 2016); doi: 10.1117/12.2210988
Proc. SPIE 9694, Synthesis and characterization of novel phthalocyanines and evaluation of photodynamic therapy properties, 969412 (1 March 2016); doi: 10.1117/12.2214072
Proc. SPIE 9694, Synthesis and characterization of PLGA nanoparticles containing mixture of curcuminoids for optimization of photodynamic inactivation, 969413 (1 March 2016); doi: 10.1117/12.2213781
Proc. SPIE 9694, Photodynamic inactivation of contaminated blood with Staphylococcus aureus, 969414 (1 March 2016); doi: 10.1117/12.2213701
Proc. SPIE 9694, Photodynamic inactivation of Acanthamoeba polyphaga with curcuminoids: an in vitro study, 969415 (1 March 2016); doi: 10.1117/12.2213130
Proc. SPIE 9694, Comparison of two photosensitizers in photodynamic therapy using light pulses in femtosecond regime: an animal study, 969417 (1 March 2016); doi: 10.1117/12.2211140
Proc. SPIE 9694, Intratumor photosensitizer injection for photodynamic therapy: Pre-clinical experience with methylene blue, Pc 4, and Photofrin, 969418 (1 March 2016); doi: 10.1117/12.2229544
Back to Top